| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |